RBC Capital lowered the firm’s price target on Accelerant (ARX) to $18 from $29 and keeps an Outperform rating on the shares. The firm is updating its model after Q3 results reflecting, in part, a deterioration in insurance intermediary multiples, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARX:
- Accelerant price target lowered to $18 from $26 at Morgan Stanley
- Accelerant price target lowered to $18 from $25 at Piper Sandler
- Accelerant upgraded to Buy from Neutral at Goldman Sachs
- Mixed Sentiment on Accelerant Holdings: Hold Rating Amid Growth and Structural Challenges
- Accelerant price target lowered to $21 from $33 at Raymond James